What is the dose of acyclovir (antiviral medication) for varicella-zoster virus infection (chickenpox) in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For adults with varicella-zoster virus infection, the recommended dose of acyclovir is 800 mg orally four times a day for 5 days, as this regimen is likely to provide the best balance of efficacy and safety based on available evidence. When considering the treatment of varicella-zoster virus infection in adults, it's crucial to prioritize regimens that have been shown to effectively reduce morbidity and mortality while improving quality of life. According to the guidelines provided by the Centers for Disease Control and Prevention 1, several dosing regimens for acyclovir are recommended, including 400 mg orally three times a day, 200 mg orally five times a day, or 800 mg orally twice a day, all for a duration of 5 days. However, the most effective dose in terms of reducing the severity and duration of symptoms, especially in adults who are at a higher risk of complications from chickenpox, would logically be the highest dose mentioned that is still considered safe and effective. Key considerations in the management of varicella-zoster virus infection include:

  • Starting treatment as soon as possible after the onset of symptoms to maximize effectiveness
  • Ensuring adequate hydration throughout the treatment period
  • Monitoring for potential side effects such as nausea, headache, and diarrhea
  • Adjusting the dose in patients with renal impairment to prevent toxicity Given the potential severity of varicella-zoster virus infection in adults and the importance of prompt and effective treatment, the 800 mg orally twice a day regimen stands out as a preferred option due to its simplicity and the higher dose of acyclovir, which may offer better viral suppression. This approach is supported by the CDC guidelines 1, which list this regimen among the recommended treatment options.

From the FDA Drug Label

Adults and Children over 40 kg: 800 mg 4 times daily for 5 days. The dose of acyclovir for varicella-zoster virus infection (chickenpox) in adults is 800 mg 4 times daily for 5 days 2.

From the Research

Dose of Acyclovir for Varicella-Zoster Virus Infection in Adults

  • The recommended dose of acyclovir for varicella-zoster virus infection in adults is 800 mg five times a day 3, 4, 5.
  • This dose is recommended for immunocompetent adults with chickenpox, and it should be administered for 5-10 days 3, 4, 5.
  • It is essential to maintain adequate hydration and urine flow when taking acyclovir, and to monitor the patient's mental status and renal function 3.
  • The dose of acyclovir may need to be adjusted in patients with impaired renal function 3.

Administration and Efficacy

  • Acyclovir can be administered orally or intravenously, depending on the severity of the infection and the patient's immune status 3, 4.
  • Oral acyclovir has been shown to be effective in reducing the duration and severity of chickenpox in adults, particularly when initiated within 24 hours of rash onset 5.
  • Acyclovir therapy has also been shown to reduce the risk of complications, such as bacterial superinfections and postherpetic neuralgia, although the evidence is limited 3, 4.

Safety and Tolerability

  • Acyclovir is generally well-tolerated, with few adverse events reported in clinical trials 3, 4, 5.
  • The most common adverse events associated with acyclovir are nausea, vomiting, and diarrhea, although these are typically mild and self-limiting 3, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Antiviral treatment in chickenpox and herpes zoster.

Journal of the American Academy of Dermatology, 1988

Research

Therapeutic approaches to varicella-zoster virus infections.

The Journal of infectious diseases, 1992

Research

A double blind, placebo controlled trial of efficacy and safety of oral acyclovir (Zovirax) in the treatment of chickenpox in adults.

Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue europeenne pour les sciences medicales et pharmacologiques, 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.